MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.

April 13, 2012

Chagas is a neglected disease that affects between eight and ten million people, mainly in Latin America. Doctors Without Borders/Médecins Sans Frontières (MSF) works in Paraguay's rural Chaco region, going into isolated communities to educate people about the disease and screen them for it. Internationally, MSF fights to improve access to diagnosis and treatment for the disease and advocates for more research and development into its treatment.

All photos by Anna Surinyach

April 05, 2012

In Paraguay, Doctors Without Borders/Médecins Sans Frontières (MSF) is covering the rural Chaco region, encouraging people to be tested and treated for Chagas, a widespread but little known and potentially fatal disease.

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

October 04, 2011

This crisis could have been prevented but the major player involved, the Brazilian Ministry of Health, has shirked its responsibilities and is evidently unwilling to overcome the various challenges. 

October 03, 2011

Chagas disease, or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi (T. cruzi) and is transmitted mainly by insects called triatomines, also known as ‘assassin bugs’ or ‘kissing bugs’. It is endemic in 21 Latin American countries and cases have also been reported in the U.S., Europe, and Japan.

June 30, 2011

Recently, Chagas projects have seen their treatment capacities limited due to a shortage in benznidazole, a first-line drug manufactured by only one laboratory in Brazil. 

Pages

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.

April 13, 2012

Chagas is a neglected disease that affects between eight and ten million people, mainly in Latin America. Doctors Without Borders/Médecins Sans Frontières (MSF) works in Paraguay's rural Chaco region, going into isolated communities to educate people about the disease and screen them for it. Internationally, MSF fights to improve access to diagnosis and treatment for the disease and advocates for more research and development into its treatment.

All photos by Anna Surinyach

April 05, 2012

In Paraguay, Doctors Without Borders/Médecins Sans Frontières (MSF) is covering the rural Chaco region, encouraging people to be tested and treated for Chagas, a widespread but little known and potentially fatal disease.

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

October 04, 2011

This crisis could have been prevented but the major player involved, the Brazilian Ministry of Health, has shirked its responsibilities and is evidently unwilling to overcome the various challenges. 

October 03, 2011

Chagas disease, or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi (T. cruzi) and is transmitted mainly by insects called triatomines, also known as ‘assassin bugs’ or ‘kissing bugs’. It is endemic in 21 Latin American countries and cases have also been reported in the U.S., Europe, and Japan.

June 30, 2011

Recently, Chagas projects have seen their treatment capacities limited due to a shortage in benznidazole, a first-line drug manufactured by only one laboratory in Brazil. 

Pages